AtriCure s Synergy Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
AtriCure, Inc. , a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, today announced that the U.S.

Recent FDA Approvals for Antares Pharma and Boston Scientific Have Done Little to Boost Shares
NEW YORK, NY-- - Unlike most of the so-called "recession proof" healthcare sector, the medical equipment and supplies industry has underperformed the S&P 500 by a rather large margin this year. ...